Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-03

Clinical Trial Update: Treximet in the Treatment of Chronic Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial of Treximet for chronic migraine has been completed and results were posted in July 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Cady, Roger, M.D. | Conditions: Chronic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2013-07-03